Pharmaceutical companies in Switzerland by P/S ratio

Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.

Novartis has the lowest figure of the 2 pharmaceutical companies in Switzerland ranked by P/S ratio, at 5.4, followed by BeOne Medicines (8.6). Figures as of 18 Nov 2026, 23:16 UTC, from Yahoo Finance quotes.

Only 2 companies have this figure here, too few to make a ranking, so this list is not offered to search engines.

Key facts

Companies ranked
2
Lowest
Novartis5.4
Combined market value
$339.2B
Countries
1

Market values as of .

Switzerland
All sectors
Pharmaceuticals
USD
Clear filters
Pharmaceutical companies in Switzerland by P/S ratio
#CompanyP/S ↑Market capPriceToday1 yearPrice, 30 daysCountry
1NovartisNVS · Health Care5.4$293.1B$155.21 2.46% down 25% up Switzerland
2BeOne MedicinesONC · Health Care8.6$46.1B$403.60 2.34% down 17% up Switzerland

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. P/S divides today's market value by the latest fiscal year's revenue from the annual report.

Questions and answers

Which pharmaceutical companies in Switzerland have the lowest P/S ratio?

Novartis (5.4) and BeOne Medicines (8.6) have the lowest P/S ratio of the 2 pharmaceutical companies in Switzerland ranked here as of 18 Nov 2026, 23:16 UTC.

How many pharmaceutical companies in Switzerland are in this ranking?

2 are ranked by P/S ratio.

What are these pharmaceutical companies in Switzerland worth together?

The 2 pharmaceutical companies in Switzerland ranked by P/S ratio have a combined market value of $339.2B as of 18 Nov 2026, 23:16 UTC.

What does ranking by P/S ratio measure?

Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.

Cite this page

Funkfolio, “Pharmaceutical companies in Switzerland by P/S ratio”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?country=switzerland&by=ps-ratio

Underlying data: Yahoo Finance; SEC EDGAR.